CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease

Brain atrophy and altered CSF levels of amyloid β (Aβ(42)) and the microtubule-associated protein tau are potent biomarkers of Alzheimer's disease (AD)-related pathology. However, the relationship between CSF biomarkers and brain morphometry is poorly understood. Thus, we addressed the followin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fjell, Anders M., Walhovd, Kristine B., Fennema-Notestine, Christine, McEvoy, Linda K., Hagler, Donald J., Holland, Dominic, Brewer, James B., Dale, Anders M.
Formato: Artigo
Idioma:Inglês
Publicado em: Society for Neuroscience 2010
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2828879/
https://ncbi.nlm.nih.gov/pubmed/20147537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.3785-09.2010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados